Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Bol Asoc Med P R ; 85(1-3): 18-20, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8060438

RESUMEN

Every citizen is morally responsible to contribute to solve the drug problem in the national front. Though we may understand that the uninformed and the naive may experiment with drugs, we do not expect patients nor hospital personnel to abuse them in the treatment environment. But hospitals are also hit by the epidemic. For long we have recognized how drug abuse adds comorbidity to medical care. But abuse of drugs by hospital personnel not only alters community expectations of health care professionals but has a tremendous impact on productivity. Here I recommend specific management strategies for the surveillance, prevention and control drug abuse within the hospital environment.


Asunto(s)
Personal de Hospital , Desarrollo de Programa , Trastornos Relacionados con Sustancias/prevención & control , Humanos , Vigilancia de la Población
2.
Bol Asoc Med P R ; 89(10-12): 157-60, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9577049

RESUMEN

UNLABELLED: The purpose of this study is to evaluate the efficacy of Naltrexone in decreasing craving symptoms among Puerto Rican male veterans with alcohol dependence. METHOD: This is a double blind placebo control study with a convenience sample of eleven patients divided in two groups (placebo and Naltrexone). Scales consisting of Zung Depression, Zung Anxiety, MMSE, OCD Screener, Craving, and Somatization were administered at baseline, and weekly for four weeks as follow up. RESULTS: There were no statistically significant differences between the two groups on any of the outcome variables at baseline or follow up measurements. A statistical trend was noted toward a decrease in somatization. A decrease in craving symptoms was observed in the experimental group. CONCLUSIONS: Even though our results did not show evidence of the efficacy of Naltrexone in decreasing craving symptoms, a small number of patients did benefit from the medication. The results could have been affected by the small sample size.


Asunto(s)
Alcoholismo/tratamiento farmacológico , Naltrexona/uso terapéutico , Adulto , Anciano , Alcoholismo/psicología , Atención Ambulatoria , Ansiedad/tratamiento farmacológico , Trastornos del Conocimiento/tratamiento farmacológico , Depresión/tratamiento farmacológico , Método Doble Ciego , Humanos , Masculino , Persona de Mediana Edad , Trastorno Obsesivo Compulsivo/tratamiento farmacológico , Proyectos Piloto , Pruebas Psicológicas , Trastornos Somatomorfos/tratamiento farmacológico , Resultado del Tratamiento
6.
Bol. Asoc. Méd. P. R ; Bol. Asoc. Méd. P. R;85(1/3): 18-20, Jan.-Mar. 1993.
Artículo en Inglés | LILACS | ID: lil-411625

RESUMEN

Every citizen is morally responsible to contribute to solve the drug problem in the national front. Though we may understand that the uninformed and the naive may experiment with drugs, we do not expect patients nor hospital personnel to abuse them in the treatment environment. But hospitals are also hit by the epidemic. For long we have recognized how drug abuse adds comorbidity to medical care. But abuse of drugs by hospital personnel not only alters community expectations of health care professionals but has a tremendous impact on productivity. Here I recommend specific management strategies for the surveillance, prevention and control drug abuse within the hospital environment


Asunto(s)
Humanos , Personal de Hospital , Desarrollo de Programa , Trastornos Relacionados con Sustancias/prevención & control , Vigilancia de la Población
7.
Bol. Asoc. Méd. P. R ; Bol. Asoc. Méd. P. R;89(10/12): 157-160, Oct.-Dec. 1997.
Artículo en Inglés | LILACS | ID: lil-411430

RESUMEN

The purpose of this study is to evaluate the efficacy of Naltrexone in decreasing craving symptoms among Puerto Rican male veterans with alcohol dependence. METHOD: This is a double blind placebo control study with a convenience sample of eleven patients divided in two groups (placebo and Naltrexone). Scales consisting of Zung Depression, Zung Anxiety, MMSE, OCD Screener, Craving, and Somatization were administered at baseline, and weekly for four weeks as follow up. RESULTS: There were no statistically significant differences between the two groups on any of the outcome variables at baseline or follow up measurements. A statistical trend was noted toward a decrease in somatization. A decrease in craving symptoms was observed in the experimental group. CONCLUSIONS: Even though our results did not show evidence of the efficacy of Naltrexone in decreasing craving symptoms, a small number of patients did benefit from the medication. The results could have been affected by the small sample size


Asunto(s)
Humanos , Masculino , Adulto , Persona de Mediana Edad , Alcoholismo/tratamiento farmacológico , Naltrexona/uso terapéutico , Atención Ambulatoria , Alcoholismo/psicología , Ansiedad/tratamiento farmacológico , Método Doble Ciego , Depresión/tratamiento farmacológico , Proyectos Piloto , Pruebas Psicológicas , Resultado del Tratamiento , Trastorno Obsesivo Compulsivo/tratamiento farmacológico , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos Somatomorfos/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA